Patent intelligence · US
US 7662800
Hyaluronic acid derivatives
Hyaluronic acid derivatives
Patent details — US 7662800
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 16, 2010
- Expiration
- Feb 11, 2030
- Applicant
- Jasper Ltd. Liability Co.
- Claims
- 27
- CPC classes
- A61K, A61K2800/57, A61K31/728, A61K47/61
Quick answer
US 7662800 (Hyaluronic acid derivatives) is held by Jasper Ltd. Liability Co.. Status: granted. Granted Feb 16, 2010. Expires Feb 11, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Jasper Ltd. Liability Co.
- Grant date
- Expiration
- Claims
- 27
- CPC classes
- A61K, A61K2800/57, A61K31/728, A61K47/61, A61K8/4953, A61K8/735
Frequently asked questions
What is US patent 7662800?
US 7662800 (Hyaluronic acid derivatives) is held by Jasper Ltd. Liability Co.. Status: granted. Granted Feb 16, 2010. Expires Feb 11, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7662800?
Jasper Ltd. Liability Co. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 7662800 expire?
Our index shows an expiration date of Feb 11, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.